GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tectonic Therapeutic Inc (NAS:TECX) » Definitions » Total Stockholders Equity

TECX (Tectonic Therapeutic) Total Stockholders Equity : $150.36 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tectonic Therapeutic Total Stockholders Equity?

Tectonic Therapeutic's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $150.36 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Tectonic Therapeutic's Book Value per Share for the quarter that ended in Sep. 2024 was $10.20. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Tectonic Therapeutic's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.02.

Tectonic Therapeutic Total Stockholders Equity Historical Data

The historical data trend for Tectonic Therapeutic's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tectonic Therapeutic Total Stockholders Equity Chart

Tectonic Therapeutic Annual Data
Trend Dec21 Dec22
Total Stockholders Equity
-14.96 -45.65

Tectonic Therapeutic Quarterly Data
Dec21 Sep22 Dec22 Jun23 Sep23 Jun24 Sep24
Total Stockholders Equity Get a 7-Day Free Trial -45.65 - -79.78 166.37 150.36

Tectonic Therapeutic  (NAS:TECX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Tectonic Therapeutic's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(150.361-0)/14.7445
=10.20

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Tectonic Therapeutic's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.948 + 1.036) / 150.361
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tectonic Therapeutic Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Tectonic Therapeutic's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tectonic Therapeutic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tectonic Therapeutic Inc (NAS:TECX) » Definitions » Total Stockholders Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
490 Arsenal Way, Suite 210, Watertown, MA, USA, 02472
Website
https://www.tectonictx.com
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.